The pharmaceutical giant AstraZeneca has scrapped plans for a £450m expansion of its childhood flu vaccine manufacturing site in Speke, Merseyside, following protracted negotiations with the UK government over state
The pharmaceutical giant AstraZeneca has scrapped plans for a £450m expansion of its childhood flu vaccine manufacturing site in Speke, Merseyside, following protracted negotiations with the UK government over state
The fate of AstraZeneca’s planned £450 million investment in a vaccine manufacturing facility in northwest England hangs in the balance as the Treasury, under the leadership of Chancellor Rachel Reeves,






